Font Size




Menu Style

Antiviral Susceptibility Reference Panels

Two panels of antiviral susceptible and resistant influenza viruses are available from the International Reagent Resource (IRR), CDC, Atlanta, USA, and can be ordered after registration and approval.

The CDC Neuraminidase Inhibitor Susceptibility Reference Virus Panel (version 3.0), IRR catalogue No. FR-1755, contains the following 8 viruses:

  1. A/Illinois/45/2019 (H1N1)pdm09, wild type;
  2. A/Alabama/03/2020 (H1N1)pdm09, NA-H275Y;
  3. A/Pennsylvania/46/2015 (H3N2), wild type;
  4. A/Washington/33/2014 (H3N2), NA-E119V;
  5. B/North Carolina/25/2018, wild type;
  6. B/Missouri/122/2018, NA-D197E;
  7. B/Laos/0080/2016, wild type;
  8. B/Laos/0654/2016, NA-H134N.

The CDC Baloxavir Susceptibility Reference Virus Panel (version 1.1), IRR catalogue No. FR-1678, contains the following 5 viruses:

  1. A/Illinois/08/2018 (H1N1)pdm09, wild type;
  2. A/Illinois/08/2018 (H1N1)pdm09, PA-I38T;
  3. A/Illinois/37/2018 (H1N1)pdm09, PA-I38L;
  4. A/Louisiana/50/2017, wild type;
  5. A/Louisiana/49/2017, PA-I38M.






Updated 17 November 2020